- Home
- OGS vs GRFS Comparison
OGS vs GRFS Comparison
Compare OGS & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGS | GRFS |
|---|---|---|
| Founded | 1906 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | OGS | GRFS |
|---|---|---|
| Price | $71.95 | $7.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | ★ $89.00 | $10.15 |
| AVG Volume (30 Days) | ★ 478.5K | 380.7K |
| Earning Date | 05-04-2026 | 07-28-2022 |
| Dividend Yield | ★ 3.10% | 1.80% |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $2,578,005,000.00 | N/A |
| Revenue This Year | $12.51 | $4.49 |
| Revenue Next Year | N/A | $6.42 |
| P/E Ratio | $26.00 | ★ $18.67 |
| Revenue Growth | ★ 42.54 | N/A |
| 52 Week Low | $71.84 | $6.96 |
| 52 Week High | $90.78 | $10.23 |
Technical Indicators
Market Signals| Indicator | OGS | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 27.39 | 33.22 |
| Support Level | N/A | $6.98 |
| Resistance Level | $81.85 | $8.41 |
| Average True Range (ATR) | 1.39 | 0.10 |
| MACD | -0.64 | -0.04 |
| Stochastic Oscillator | 8.67 | 0.00 |
Price Performance
Historical ComparisonAbout OGS ONE Gas Inc.
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.